SC 13D Filing

Company

Indaptus Therapeutics, Inc.

Filed

August 13, 2021

Accession Number

0001493152-21-019686

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →